Institute of Pharmacology of Natural Products & Clinical Pharmacology, University Hospital Ulm, Ulm, Germany.
Institute of Pharmacology of Natural Products & Clinical Pharmacology, University Hospital Ulm, Ulm, Germany.
Int J Oral Maxillofac Surg. 2020 Apr;49(4):522-528. doi: 10.1016/j.ijom.2019.09.007. Epub 2019 Sep 27.
Infective endocarditis (IE) is a devastating disease with high mortality. Most guidelines recommend routine use of antibiotic prophylaxis during oral surgery to prevent IE in patients with specific predisposing cardiac conditions, but this is not the case in the UK. The conflicting opinions and guidance are confusing and may affect IE prophylaxis implementation. We investigated how IE prophylaxis standards are defined in hospitals and outpatient clinics of oral and maxillofacial surgery. A survey was sent to 80 surgeons heading departments of oral and maxillofacial surgery in Germany. We observed significant heterogeneity in IE prophylaxis implementation among the clinics. This diversity was in relation to the definition of predisposing cardiac conditions, the type of dental and surgical procedures performed that require IE prophylaxis, the spectrum of compounds used, and the timing of antibiotic prophylaxis. We observed under-prescription of IE prophylaxis in high-risk patients, the overuse of antibiotic prophylaxis in patients not at high risk of IE, and the use of inappropriate drugs. These findings suggest that educational strategies and guideline implementation advice are needed to improve standards of IE prophylaxis in oral and maxillofacial surgery clinics.
感染性心内膜炎(IE)是一种死亡率很高的破坏性疾病。大多数指南建议在口腔手术期间常规使用抗生素预防用药,以预防具有特定易患心脏条件的患者发生 IE,但在英国并非如此。相互矛盾的意见和指南令人困惑,可能会影响 IE 预防用药的实施。我们调查了口腔颌面外科医院和门诊诊所如何定义 IE 预防用药标准。我们向德国 80 名负责口腔颌面外科部门的外科医生发送了一份调查。我们观察到诊所之间在实施 IE 预防用药方面存在显著的异质性。这种多样性与易患心脏条件的定义、需要 IE 预防用药的牙科和手术类型、使用的化合物种类以及抗生素预防用药的时间有关。我们观察到高危患者的 IE 预防用药不足,非 IE 高危患者的预防用药过度,以及使用不适当的药物。这些发现表明,需要教育策略和指南实施建议来提高口腔颌面外科诊所的 IE 预防用药标准。